JPRN-UMIN000032334已完成未知
A study for safety evaluation of long-term consumption of the test food. - A study for safety evaluation of long-term consumption of the test food.
CPCC Co., Ltd.0 个研究点目标入组 30 人开始时间: 2019年8月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
It was judged that there was no problem in safety.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 59years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Subjects who have lactose intolerance. (2) Subjects who can't refrain restricted and/or prohibited foods during the test. (3) Subjects who take medications that affect intestinal environment, digestion and absorption at the time of advance inspection. (4) Subjects who regularly use laxatives, intestinal regulator, etc. (5) Pregnant or possibly pregnant, or lactating women. (6) Subjects who have a history of and/or current medical history of severe diseases such as heart, liver, kidney, digestive organs, drug dependence, alcohol dependence. (7) Subjects who excessive alcohol intake. (8) Subjects who have extremely irregular life rhythms, and have midnight work or irregular shift work. (9) Subjects who have previous medical history of drug and/or food allergy. (10) Subjects who have chronic illness and regularly use medicines. (11) Subjects who were judged unsuitable for the clinical test from the results of the blood test at advance inspection. (12) Subjects who are participating the other clinical tests and participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. (13) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. (14) Males who donated over 400mL blood and/or blood components within the last three months to the current study. (15) Females who donated over 400mL blood and/or blood components within the last four months to the current study. (16) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. (17) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. (18) Others who have been determined ineligible by principal investigator or sub-investigator.
研究者
相似试验
已完成
不适用
A study for safety evaluation of excess consumption of the test food.Healthy adultJPRN-UMIN000032335CPCC Co., Ltd.30
进行中（未招募）
1 期
ong-term Follow-up Study of Male Adults with Hemophilia B Previously Treated with Etranacogene Dezaparvovec (CSL222)MedDRA version: 20.0Level: LLTClassification code: 10018939Term: Haemophilia B (Factor IX) Class: 10010331Hemophilia BCTIS2023-503765-37-00CSL Behring LLC56
招募中
2 期
A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions10040998Narcolepsy type 1 and 2sleeping disorderNL-OMON53942Takeda Development Center Americas, Inc.2
进行中（未招募）
1 期
A Study to Evaluate the Long-term Safety and Tolerability of TAK-861arcolepsy with Cataplexy (Type 1) and Narcolepsy without Cataplexy (Type 2)MedDRA version: 20.0Level: PTClassification code 10028713Term: NarcolepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2022-002965-13-FITakeda Development Center Americas, Inc.160
进行中（未招募）
1 期
A Study to Evaluate the Long-term Safety and Tolerability of TAK-861MedDRA version: 20.0Level: PTClassification code 10028713Term: NarcolepsySystem Organ Class: 10029205 - Nervous system disordersarcolepsy with Cataplexy (Type 1) and Narcolepsy without Cataplexy (Type 2)EUCTR2022-002965-13-SETakeda Development Center Americas, Inc.160